Global Drug Repositioning Market Research Report 2026(Status and Outlook)

May 2026 | 103 pages | ID: G6BB7BEFF815EN
Bosson Research

Abstracts

Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.The drug repositioning market is driven by the growing demand for cost-effective and time-saving drug development strategies. Traditional drug discovery can take over a decade and cost billions of dollars, with a high risk of failure during clinical trials. Repositioning, on the other hand, allows pharmaceutical companies to repurpose known drugs with existing safety and pharmacokinetic profiles, thereby accelerating time to market and reducing development risk. This approach is especially appealing for rare diseases, cancer, and neurodegenerative disorders where treatment options are limited. Additionally, advances in data mining, artificial intelligence, and systems biology have improved the ability to identify new drug-disease relationships, fueling further interest. Regulatory agencies such as the FDA and EMA also support repositioning by offering faster review pathways and incentives for orphan indications, making this strategy increasingly viable from a business perspective.Despite its advantages, the drug repositioning market faces several challenges. One of the major issues is intellectual property protection—many repositioned drugs are off-patent, making it difficult for companies to secure exclusivity and justify investment. In cases where patent life can be extended through new formulations or uses, legal and regulatory hurdles still exist. Another challenge lies in clinical validation; while safety data may already be available, proving efficacy for a new indication still requires substantial clinical trial investment. Moreover, the lack of centralized, standardized databases for repositioning candidates limits discovery efficiency. The fragmented nature of available data—spread across academic publications, clinical trial registries, and real-world evidence—makes it hard to integrate and analyze comprehensively. Finally, collaboration between industry and academia, which is crucial for repositioning, is often hindered by misaligned goals and timelines.

The global Drug Repositioning market size was estimated at USD 28780.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.70% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Drug Repositioning market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Drug Repositioning market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Drug Repositioning market.

Global Drug Repositioning Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

• Teva
• Novartis
• Mylan
• Johnson & Johnson
• Pfizer
• Bausch Health
• GSK
• ChemRar Group
• Glenmark
• Fujifilm
• Dr. Reddy
• R-Pharma

Market Segmentation (by Type)

• Generic Drugs
• Clinical Trial Failed Drugs

Market Segmentation (by Application)

• Cardiovascular Diseases
• Mental Illness
• Cancer
• Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Drug Repositioning Market

Overview of the regional outlook of the Drug Repositioning Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug Repositioning Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Drug Repositioning, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Drug Repositioning
1.2 Key Market Segments
  1.2.1 Drug Repositioning Segment by Type
  1.2.2 Drug Repositioning Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 DRUG REPOSITIONING MARKET OVERVIEW

2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 DRUG REPOSITIONING MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Drug Repositioning Product Life Cycle
3.3 Global Drug Repositioning Revenue Market Share by Company (2020-2025)
3.4 Drug Repositioning Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Drug Repositioning Market Competitive Situation and Trends
  3.6.1 Drug Repositioning Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Drug Repositioning Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 DRUG REPOSITIONING VALUE CHAIN ANALYSIS

4.1 Drug Repositioning Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF DRUG REPOSITIONING MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Drug Repositioning Market Porter's Five Forces Analysis

6 DRUG REPOSITIONING MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Drug Repositioning Market by Type (2020-2025)
6.3 Global Drug Repositioning Market Size Growth Rate by Type (2021-2025)

7 DRUG REPOSITIONING MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Drug Repositioning Market Size (M USD) by Application (2020-2025)
7.3 Global Drug Repositioning Market Size Growth Rate by Application (2021-2025)

8 DRUG REPOSITIONING MARKET SEGMENTATION BY REGION

8.1 Global Drug Repositioning Market Size by Region
  8.1.1 Global Drug Repositioning Market Size by Region
  8.1.2 Global Drug Repositioning Market Size Market Share by Region
8.2 North America
  8.2.1 North America Drug Repositioning Market Size by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Drug Repositioning Market Size by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Spain
8.4 Asia Pacific
  8.4.1 Asia Pacific Drug Repositioning Market Size by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Drug Repositioning Market Size by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Drug Repositioning Market Size by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 Teva
  9.1.1 Teva Basic Information
  9.1.2 Teva Drug Repositioning Product Overview
  9.1.3 Teva Drug Repositioning Product Market Performance
  9.1.4 Teva SWOT Analysis
  9.1.5 Teva Business Overview
  9.1.6 Teva Recent Developments
9.2 Novartis
  9.2.1 Novartis Basic Information
  9.2.2 Novartis Drug Repositioning Product Overview
  9.2.3 Novartis Drug Repositioning Product Market Performance
  9.2.4 Novartis SWOT Analysis
  9.2.5 Novartis Business Overview
  9.2.6 Novartis Recent Developments
9.3 Mylan
  9.3.1 Mylan Basic Information
  9.3.2 Mylan Drug Repositioning Product Overview
  9.3.3 Mylan Drug Repositioning Product Market Performance
  9.3.4 Mylan SWOT Analysis
  9.3.5 Mylan Business Overview
  9.3.6 Mylan Recent Developments
9.4 Johnson and Johnson
  9.4.1 Johnson and Johnson Basic Information
  9.4.2 Johnson and Johnson Drug Repositioning Product Overview
  9.4.3 Johnson and Johnson Drug Repositioning Product Market Performance
  9.4.4 Johnson and Johnson Business Overview
  9.4.5 Johnson and Johnson Recent Developments
9.5 Pfizer
  9.5.1 Pfizer Basic Information
  9.5.2 Pfizer Drug Repositioning Product Overview
  9.5.3 Pfizer Drug Repositioning Product Market Performance
  9.5.4 Pfizer Business Overview
  9.5.5 Pfizer Recent Developments
9.6 Bausch Health
  9.6.1 Bausch Health Basic Information
  9.6.2 Bausch Health Drug Repositioning Product Overview
  9.6.3 Bausch Health Drug Repositioning Product Market Performance
  9.6.4 Bausch Health Business Overview
  9.6.5 Bausch Health Recent Developments
9.7 GSK
  9.7.1 GSK Basic Information
  9.7.2 GSK Drug Repositioning Product Overview
  9.7.3 GSK Drug Repositioning Product Market Performance
  9.7.4 GSK Business Overview
  9.7.5 GSK Recent Developments
9.8 ChemRar Group
  9.8.1 ChemRar Group Basic Information
  9.8.2 ChemRar Group Drug Repositioning Product Overview
  9.8.3 ChemRar Group Drug Repositioning Product Market Performance
  9.8.4 ChemRar Group Business Overview
  9.8.5 ChemRar Group Recent Developments
9.9 Glenmark
  9.9.1 Glenmark Basic Information
  9.9.2 Glenmark Drug Repositioning Product Overview
  9.9.3 Glenmark Drug Repositioning Product Market Performance
  9.9.4 Glenmark Business Overview
  9.9.5 Glenmark Recent Developments
9.10 Fujifilm
  9.10.1 Fujifilm Basic Information
  9.10.2 Fujifilm Drug Repositioning Product Overview
  9.10.3 Fujifilm Drug Repositioning Product Market Performance
  9.10.4 Fujifilm Business Overview
  9.10.5 Fujifilm Recent Developments
9.11 Dr. Reddy
  9.11.1 Dr. Reddy Basic Information
  9.11.2 Dr. Reddy Drug Repositioning Product Overview
  9.11.3 Dr. Reddy Drug Repositioning Product Market Performance
  9.11.4 Dr. Reddy Business Overview
  9.11.5 Dr. Reddy Recent Developments
9.12 R-Pharma
  9.12.1 R-Pharma Basic Information
  9.12.2 R-Pharma Drug Repositioning Product Overview
  9.12.3 R-Pharma Drug Repositioning Product Market Performance
  9.12.4 R-Pharma Business Overview
  9.12.5 R-Pharma Recent Developments

10 DRUG REPOSITIONING MARKET FORECAST BY REGION

10.1 Global Drug Repositioning Market Size Forecast
10.2 Global Drug Repositioning Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Drug Repositioning Market Size Forecast by Country
  10.2.3 Asia Pacific Drug Repositioning Market Size Forecast by Region
  10.2.4 South America Drug Repositioning Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Sales of Drug Repositioning by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

11.1 Global Drug Repositioning Market Forecast by Type (2026-2035)
  11.1.1 Global Drug Repositioning Market Size Forecast by Type (2026-2035)
11.2 Global Drug Repositioning Market Forecast by Application (2026-2035)
  11.2.1 Global Drug Repositioning Market Size (M USD) Forecast by Application (2026-2035)

12 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Drug Repositioning Market Size by Type (M USD)
Table 4. Global Drug Repositioning Market Size by Application
Table 5. Drug Repositioning Market Size Comparison by Region (M USD)
Table 6. Global Drug Repositioning Revenue (M USD) by Company (2020-2025)
Table 7. Global Drug Repositioning Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Repositioning as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Drug Repositioning Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Drug Repositioning Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Drug Repositioning Market Size by Type (M USD)
Table 22. Global Drug Repositioning Market Size (M USD) by Type (2020-2025)
Table 23. Global Drug Repositioning Market Share by Type (2020-2025)
Table 24. Global Drug Repositioning Market Size Growth Rate by Type (2021-2025)
Table 25. Global Drug Repositioning Market Size by Application
Table 26. Global Drug Repositioning Market Size by Application (2020-2025) & (M USD)
Table 27. Global Drug Repositioning Market Share by Application (2020-2025)
Table 28. Global Drug Repositioning Market Size Growth Rate by Application (2021-2025)
Table 29. Global Drug Repositioning Market Size by Region (2020-2025) & (M USD)
Table 30. Global Drug Repositioning Market Size Market Share by Region (2020-2025)
Table 31. North America Drug Repositioning Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Drug Repositioning Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Drug Repositioning Market Size by Region (2020-2025) & (M USD)
Table 34. South America Drug Repositioning Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Drug Repositioning Market Size by Region (2020-2025) & (M USD)
Table 36. Teva Basic Information
Table 37. Teva Drug Repositioning Product Overview
Table 38. Teva Drug Repositioning Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Teva SWOT Analysis
Table 40. Teva Business Overview
Table 41. Teva Recent Developments
Table 42. Novartis Basic Information
Table 43. Novartis Drug Repositioning Product Overview
Table 44. Novartis Drug Repositioning Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Novartis SWOT Analysis
Table 46. Novartis Business Overview
Table 47. Novartis Recent Developments
Table 48. Mylan Basic Information
Table 49. Mylan Drug Repositioning Product Overview
Table 50. Mylan Drug Repositioning Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Mylan SWOT Analysis
Table 52. Mylan Business Overview
Table 53. Mylan Recent Developments
Table 54. Johnson and Johnson Basic Information
Table 55. Johnson and Johnson Drug Repositioning Product Overview
Table 56. Johnson and Johnson Drug Repositioning Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Johnson and Johnson Business Overview
Table 58. Johnson and Johnson Recent Developments
Table 59. Pfizer Basic Information
Table 60. Pfizer Drug Repositioning Product Overview
Table 61. Pfizer Drug Repositioning Revenue (M USD) and Gross Margin (2020-2025)
Table 62. Pfizer Business Overview
Table 63. Pfizer Recent Developments
Table 64. Bausch Health Basic Information
Table 65. Bausch Health Drug Repositioning Product Overview
Table 66. Bausch Health Drug Repositioning Revenue (M USD) and Gross Margin (2020-2025)
Table 67. Bausch Health Business Overview
Table 68. Bausch Health Recent Developments
Table 69. GSK Basic Information
Table 70. GSK Drug Repositioning Product Overview
Table 71. GSK Drug Repositioning Revenue (M USD) and Gross Margin (2020-2025)
Table 72. GSK Business Overview
Table 73. GSK Recent Developments
Table 74. ChemRar Group Basic Information
Table 75. ChemRar Group Drug Repositioning Product Overview
Table 76. ChemRar Group Drug Repositioning Revenue (M USD) and Gross Margin (2020-2025)
Table 77. ChemRar Group Business Overview
Table 78. ChemRar Group Recent Developments
Table 79. Glenmark Basic Information
Table 80. Glenmark Drug Repositioning Product Overview
Table 81. Glenmark Drug Repositioning Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Glenmark Business Overview
Table 83. Glenmark Recent Developments
Table 84. Fujifilm Basic Information
Table 85. Fujifilm Drug Repositioning Product Overview
Table 86. Fujifilm Drug Repositioning Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Fujifilm Business Overview
Table 88. Fujifilm Recent Developments
Table 89. Dr. Reddy Basic Information
Table 90. Dr. Reddy Drug Repositioning Product Overview
Table 91. Dr. Reddy Drug Repositioning Revenue (M USD) and Gross Margin (2020-2025)
Table 92. Dr. Reddy Business Overview
Table 93. Dr. Reddy Recent Developments
Table 94. R-Pharma Basic Information
Table 95. R-Pharma Drug Repositioning Product Overview
Table 96. R-Pharma Drug Repositioning Revenue (M USD) and Gross Margin (2020-2025)
Table 97. R-Pharma Business Overview
Table 98. R-Pharma Recent Developments
Table 99. Global Drug Repositioning Market Size Forecast by Region (2026-2035) & (M USD)
Table 100. North America Drug Repositioning Market Size Forecast by Country (2026-2035) & (M USD)
Table 101. Europe Drug Repositioning Market Size Forecast by Country (2026-2035) & (M USD)
Table 102. Asia Pacific Drug Repositioning Market Size Forecast by Region (2026-2035) & (M USD)
Table 103. South America Drug Repositioning Market Size Forecast by Country (2026-2035) & (M USD)
Table 104. Middle East and Africa Drug Repositioning Market Size Forecast by Country (2026-2035) & (M USD)
Table 105. Global Drug Repositioning Market Size Forecast by Type (2026-2035) & (M USD)
Table 106. Global Drug Repositioning Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Industry Chain of Drug Repositioning
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Drug Repositioning Market Size (M USD), 2025-2035
Figure 5. Global Drug Repositioning Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Drug Repositioning Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Drug Repositioning Product Life Cycle
Figure 12. Global Drug Repositioning Revenue Share by Company in 2025
Figure 13. Drug Repositioning Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Drug Repositioning Revenue in 2025
Figure 15. Value Chain Map of Drug Repositioning
Figure 16. Global Drug Repositioning Market PEST Analysis
Figure 17. Global Drug Repositioning Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Drug Repositioning Market Share by Type
Figure 20. Market Share of Drug Repositioning by Type (2020-2025)
Figure 21. Global Drug Repositioning Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Drug Repositioning Market Share by Application
Figure 24. Global Drug Repositioning Market Share by Application (2020-2025)
Figure 25. Global Drug Repositioning Market Share by Application in 2024
Figure 26. Global Drug Repositioning Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Drug Repositioning Market Size Market Share by Region (2020-2025)
Figure 28. North America Drug Repositioning Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Drug Repositioning Market Size Market Share by Country in 2024
Figure 30. U.S. Drug Repositioning Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Drug Repositioning Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Drug Repositioning Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Drug Repositioning Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Drug Repositioning Market Share by Country in 2024
Figure 35. Germany Drug Repositioning Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Drug Repositioning Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Drug Repositioning Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Drug Repositioning Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Drug Repositioning Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Drug Repositioning Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Drug Repositioning Market Size Market Share by Region in 2024
Figure 42. China Drug Repositioning Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Drug Repositioning Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Drug Repositioning Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Drug Repositioning Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Drug Repositioning Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Drug Repositioning Market Size and Growth Rate (M USD)
Figure 48. South America Drug Repositioning Market Size Market Share by Country in 2024
Figure 49. Brazil Drug Repositioning Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Drug Repositioning Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Drug Repositioning Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Drug Repositioning Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Drug Repositioning Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Drug Repositioning Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Drug Repositioning Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Drug Repositioning Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Drug Repositioning Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Drug Repositioning Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Drug Repositioning Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Drug Repositioning Market Share Forecast by Type (2026-2035)
Figure 61. Global Drug Repositioning Market Share Forecast by Application (2026-2035)